The Airship has finally landed in Among Us! Join Player, Mr. Cheese, and the rest of the gang on the brand new map with all ...

A person living in New York tested positive for the mosquito-borne chikungunya virus in the first reported transmission within the US in six years, officials said on Tuesday. The chikungunya virus is ...

While OpenAI's Sora 2 has been getting all the attention recently, we found in our comparison that Google Veo 3 is a more capable video generation model altogether. Now, however, it looks like Google ...

A new MacBook is here — and it's using Apple's new M5 chip. On Wednesday, Apple unveiled the new 14‑inch MacBook Pro. It's powered by the M5 chip and macOS Tahoe, is loaded with AI features, and has ...

OpenAI has announced a number of projects this year with foreign governments to help build out what it has called their “sovereign AI” systems. The company says the deals, some of which are being ...

New tariffs on furniture and wood products went into effect on Tuesday. With new tariffs taking effect Tuesday on furniture and lumber, an analysis released by Goldman Sachs finds American consumers ...

Good Tuesday afternoon in New York City, where it doesn't seem like we're going nuclear anytime soon. Gothamist is funded by sponsors and member donations Gothamist is funded by sponsors and member ...

The American National Standards Institute (ANSI) has approved a new American National Standard developed in partnership with the Solar Energy Industries Association (SEIA). The standard, called ...

The NFL is a win-now league and rookies, particularly the first-round variety, are expected to produce sooner rather than later. The best talent usually creates an impact sooner anyhow, thus a look ...

Economists are warning that the fate of California and New York’s economy could determine whether the entire country is able to avoid—or slips into—a recession. “I do think we're on shaky ground here, ...

Nimacimab, a new type of anti-obesity drug with a different mode of action – it targets the body’s endocannabinoid system – has shown promising results in a Phase 2a clinical trial, significantly ...